Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Schmucker-Von Koch J"" wg kryterium: Wszystkie pola


Tytuł :
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative: Jnci-Journal of the National Cancer Institute
Autorzy :
Zikos, E.
Coens, C.
Quinten, C.
Ediebah, D.E.
Martinelli, F.
Ghislain, I.
King, M.T.
Gotay, C.
Ringash, J.
Velikova, G.
Reeve, B.
Greimel, E.
Cleeland, C.S.
Flechtner, H.
Taphoorn, M. J. B.
Weis, J.
Schmucker-von Koch, J.
Sprangers, Mirjam A. G.
Bottomley, A.
Eortc, Probe
Pokaż więcej
Temat :
humanities
Źródło :
Journal of the National Cancer Institute, 108. Oxford University Press
Tytuł :
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients
Autorzy :
Quinten, C
Coens, C
Ghislain, I
Zikos, E
Sprangers, MA
Ringash, J
Martinelli, F
Ediebah, DE
Maringwa, J
Reeve, BB
Greimel, E
King, MT
Bjordal, K
Flechtner, HH
Schmucker-Von Koch, J
Taphoorn, MJ
Weis, J
Wildiers, H
Velikova, G
Bottomley, A
Pokaż więcej
Temat :
humanities
Źródło :
European Journal of Cancer, 51(18), 2808 - 2819. Pergamon
European journal of cancer (Oxford, England, 51(18), 2808 - 2819. Elsevier Limited
Opis pliku :
application/pdf
Tytuł :
CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL: A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials
Autorzy :
Ediebah, D.E.
Quinten, C.
Coens, C.
Zikos, E.
Ringash, J.
Gotay, C.
Flechtner, H.H.
Osoba, D.
King, M.
Cleeland, C.
Greimel, E.
Reeve, B.B.
Taphoorn, M.
Schmucker-Von Koch, J.
Weis, J.
Bottomley, A.
Pokaż więcej
Temat :
Public Health, Environmental and Occupational Health
Health Policy
Źródło :
Value in Health. 14
Tytuł :
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Autorzy :
Maringwa, J.
Quinten, C.
King, M.
Ringash, J.
Osoba, D.
Coens, C.
Martinelli, F.
Reeve, B.B.
Gotay, C.
Greimel, E.
Flechtner, H.
Cleeland, C.S.
Schmucker-Von Koch, J.
Weis, J.
Van Den Bent, M.J.
Stupp, R.
Taphoorn, M.J.
Bottomley, A.
on behalf of the EORTC PROBE, Project
Pokaż więcej
Temat :
humanities
Źródło :
Annals of Oncology, vol. 22, no. 9, pp. 2107-2112
Opis pliku :
application/pdf
Tytuł :
PCN127 MINIMAL CLINICALLY MEANINGFUL DIFFERENCES FOR THE EORTC QLQ-C30 AND EORTC QLQ-BN20 SCALES IN BRAIN CANCER PATIENTS
Autorzy :
Maringwa, J
Quinten, C
King, M
Ringash, J
Osoba, D
Coens, C
Martinelli, F
Cleeland, C
Flechtner, H
Gotay, C
Greimel, E
Taphoorn, M
Reeve, B
Schmucker-Von, Koch J
Weis, J
Van Den Bent, MJ
Stupp, R
Bottomley, A
Pokaż więcej
Temat :
Public Health, Environmental and Occupational Health
Health Policy
Źródło :
Value in Health. 13
Tytuł :
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Autorzy :
Ediebah, D E
Coens, C
Zikos, E
Quinten, C
Ringash, J
King, M T
Schmucker von Koch, J
Gotay, C
Greimel, E
Flechtner, H
Weis, J
Reeve, B B
Smit, E F
Taphoorn, M J B
Bottomley, A
Pokaż więcej
Temat :
LUNG cancer
LUNG cancer -- Treatment
QUALITY of life
CANCER prognosis
Źródło :
British Journal of Cancer; 5/13/2014, Vol. 110 Issue 10, p2427-2433, 7p
Przedsiębiorstwo/ jednostka :
EUROPEAN Organization for Research on Treatment of Cancer
Czasopismo naukowe
Tytuł :
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.
Autorzy :
Zikos E; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS) .
Coens C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Quinten C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Ediebah DE; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Martinelli F; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Ghislain I; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
King MT; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Gotay C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Ringash J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Velikova G; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Reeve BB; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Greimel E; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Cleeland CS; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Flechtner H; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Taphoorn MJ; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Weis J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Schmucker-von Koch J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Sprangers MA; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Bottomley A; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Pokaż więcej
Corporate Authors :
EORTC PROBE
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Dec 28; Vol. 108 (5). Date of Electronic Publication: 2015 Dec 28 (Print Publication: 2016).
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Health Status*
Quality of Life*
Neoplasms/*psychology
Neoplasms/*therapy
Constipation/etiology ; Europe ; Fatigue/etiology ; Humans ; Nausea/etiology ; Patient Satisfaction ; Prognosis ; Randomized Controlled Trials as Topic ; Research Design ; Self Report ; Survival Analysis ; Treatment Outcome ; Vomiting/etiology
Czasopismo naukowe
Tytuł :
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients.
Autorzy :
Quinten C; European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Tomtebodavagen 11A, 171 83 Stockholm, Sweden. Electronic address: .
Coens C; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Ghislain I; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Zikos E; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Sprangers MA; Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: .
Ringash J; The Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada. Electronic address: .
Martinelli F; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Ediebah DE; Clinical Research, Abbott Vascular International BVBA, Park Lane, Culliganlaan 2B, 1831 Diegem, Belgium. Electronic address: .
Maringwa J; Quantative Solutions, Parkstraat 1b, 4818 SJ Breda, The Netherlands. Electronic address: j..
Reeve BB; Gillings School of Global Public Health, University of North Caroline at Chapel Hill, 1101-D Mc Gavran-Greenberg Building, 135 Dauer Drive, CB 7411, Chapel Hill, NC 27599-7411, United States. Electronic address: .
Greimel E; Medical University Graz, Auenbruggerplatz 14, AT 8036 Graz, Austria. Electronic address: .
King MT; Cancer Australia Chair in Cancer Quality of Life, School of Psychology and Sydney Medical School, University of Sydney, New South Wales 2006, Australia. Electronic address: .
Bjordal K; Research Support Services, Oslo University Hospital, Sogn Arena, Pb 4950 Nydalen, NO-0424 Oslo, Norway. Electronic address: .
Flechtner HH; Child and Adolescent Psychiatry and Psychotherapy, Leipzigerstrasse 44, University of Magdeburg, 39120 Magdeburg, Germany. Electronic address: .
Schmucker-Von Koch J; Medical Ethics, Philosophical Faculty, University of Regensburg, Universitaetstrasse 31, 93040 Regensburg, Germany. Electronic address: joseph.schmucker-von-koch@psk.uni-regensburg.de.
Taphoorn MJ; VU Medical Center, De Boelelaan 1118, 1081 HZ Amsterdam, The Netherlands; Medical Center Haaglanden, P.O. Box 432, Lijnbaan 2, NL 2501 CK The Hague, The Netherlands. Electronic address: .
Weis J; Tumor Biology Center University Hospital Freiburg, Breisacherstrasse 117, 79106 Freiburg, Germany. Electronic address: .
Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: .
Velikova G; Faculty of Medicine and Health, Leeds Institute of Cancer & Pathology, University of Leeds, Bexley Wing (Level 4), St James's Hospital, Beckett Street, Leeds LS9 7TH, UK. Electronic address: .
Bottomley A; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Pokaż więcej
Corporate Authors :
PROBE
EORTC Clinical Groups
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 Dec; Vol. 51 (18), pp. 2808-19. Date of Electronic Publication: 2015 Nov 19.
Typ publikacji :
Journal Article; Meta-Analysis; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Aging/*psychology
Neoplasms/*psychology
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Australia ; Europe ; Female ; Geriatric Assessment ; Humans ; Linear Models ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Metastasis ; Neoplasms/diagnosis ; Neoplasms/therapy ; New Zealand ; North America ; Prognosis ; Randomized Controlled Trials as Topic ; Risk Factors ; South Africa ; Surveys and Questionnaires ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients.
Autorzy :
Ediebah, D. E.
Coens, C.
Maringwa, J. T.
Quinten, C.
Zikos, E.
Ringash, J.
King, M.
Gotay, C.
Flechtner, H.-H.
Schmucker von Koch, J.
Weis, J.
Smit, E. F.
Köhne, C.-H.
Bottomley, A.
Pokaż więcej
Temat :
CANCER patients
COMPLETION fluids
TREATMENT effectiveness
QUALITY of life
CANCER treatment
QUESTIONNAIRES
CLINICAL trials
Źródło :
Annals of Oncology; Jan2013, Vol. 24 Issue 1, p231-237, 7p
Czasopismo naukowe
Tytuł :
The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer.
Autorzy :
Koyama, Nanako (AUTHOR)
Matsumura, Chikako (AUTHOR)
Shitashimizu, Yoshihiro (AUTHOR)
Sako, Morito (AUTHOR)
Kurosawa, Hideo (AUTHOR)
Nomura, Takehisa (AUTHOR)
Eguchi, Yuki (AUTHOR)
Ohba, Kazuki (AUTHOR)
Yano, Yoshitaka (AUTHOR)
Pokaż więcej
Źródło :
BMC Cancer. 3/23/2021, Vol. 21 Issue 1, p1-8. 8p.
Czasopismo naukowe
Tytuł :
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Autorzy :
Quinten C; Quality of Life Department, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Martinelli F
Coens C
Sprangers MA
Ringash J
Gotay C
Bjordal K
Greimel E
Reeve BB
Maringwa J
Ediebah DE
Zikos E
King MT
Osoba D
Taphoorn MJ
Flechtner H
Schmucker-Von Koch J
Weis J
Bottomley A
Pokaż więcej
Corporate Authors :
Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups
Źródło :
Cancer [Cancer] 2014 Jan 15; Vol. 120 (2), pp. 302-11. Date of Electronic Publication: 2013 Oct 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Neoplasms/*etiology
Neoplasms/*mortality
Aged ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Self-Assessment
Czasopismo naukowe
Tytuł :
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Autorzy :
Quinten C; Quality of Life Department, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium. />Maringwa J
Gotay CC
Martinelli F
Coens C
Reeve BB
Flechtner H
Greimel E
King M
Osoba D
Cleeland C
Ringash J
Schmucker-Von Koch J
Taphoorn MJ
Weis J
Bottomley A
Pokaż więcej
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2011 Dec 21; Vol. 103 (24), pp. 1851-8. Date of Electronic Publication: 2011 Dec 07.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Self Report*
Neoplasms/*complications
Neoplasms/*mortality
Adult ; Aged ; Clinical Trials as Topic ; Confounding Factors, Epidemiologic ; Constipation/etiology ; Diarrhea/etiology ; Europe/epidemiology ; Fatigue/etiology ; Female ; Humans ; Male ; Middle Aged ; Nausea/etiology ; Neoplasms/therapy ; Pain/etiology ; Predictive Value of Tests ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Severity of Illness Index ; Surveys and Questionnaires ; Survival ; Survival Analysis ; Terminology as Topic ; United States/epidemiology ; Vomiting/etiology
Czasopismo naukowe
Tytuł :
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative.
Autorzy :
Bottomley A
Quinten C
Coens C
Martinelli F
Mauer M
Maringwa J
Cleeland CS
Flechtner H
Gotay C
Greimel E
King M
Osoba D
Taphoorn MJ
Reeve BB
Ringash J
Schmucker-Von Koch J
Weis J
Pokaż więcej
Źródło :
European journal of cancer care [Eur J Cancer Care (Engl)] 2009 Mar; Vol. 18 (2), pp. 105-7.
Typ publikacji :
Editorial
MeSH Terms :
International Cooperation*
Neoplasms/*therapy
Health Status ; Humans ; Quality of Life ; Treatment Outcome
Opinia redakcyjna
Tytuł :
Prospective patient-reported symptom profiles associated with pediatric acute lymphoblastic leukemia relapse.
Autorzy :
Brown, Austin L.
Raghubar, Kimberly P.
Taylor, Olga A.
Bernhardt, Melanie Brooke
Kahalley, Lisa S.
Pan, Wei
Lupo, Philip J.
Hockenberry, Marilyn J.
Scheurer, Michael E.
Pokaż więcej
Temat :
LYMPHOBLASTIC leukemia
ACUTE leukemia
PROPORTIONAL hazards models
SYMPTOMS
CANCER fatigue
CHILD patients
CANCER relapse
Źródło :
Supportive Care in Cancer; May2021, Vol. 29 Issue 5, p2455-2464, 10p
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies